Feb 11, 2016 at 08:00 | Source: Moneycontrol.com
Janet Yellen stuck to the script and made it clear that the central bank remains on a path of 'gradual' policy tightening. Yet she highlighted growing risks facing the economy.
Feb 10, 2016 at 08:32 | Source: Moneycontrol.com
Global bear is clearly not in a mood to relent and you are going to have an ugly start today morning going by the SGX Nifty. Pretty close to the previous 52-week low of the Nifty and the Bank Nifty, there is a good chance that you would breach that intraday today.
Feb 10, 2016 at 07:56 | Source: Moneycontrol.com
Indian shares are likely to open weak, following a day of heavy losses, as selling continues to linger in some key global markets, such as the Japan and Singapore.
Feb 09, 2016 at 07:58 | Source: Moneycontrol.com
Indian shares will likely be off to a weak start after negative sentiment appears to have again engulfed risk assets.
Feb 08, 2016 at 07:58 | Source: Moneycontrol.com
Nifty expected to open in green boosted by government's move to protect the steel sector and positive earnings. SGX Nifty was trading at 7477 down 30 points at 7:50 AM today.
Feb 05, 2016 at 07:55 | Source: Moneycontrol.com
Lupin will be reporting its numbers and expectation is that it is likely to be a subdued quarter with revenue rising 7.3 percent.
Feb 04, 2016 at 07:54 | Source: Moneycontrol.com
Indian stocks are expected to open in the green, after a bounceback in crude prices sent global shares rising.
Feb 02, 2016 at 07:52 | Source: Moneycontrol.com
With the markets world over closing lower and SGX Nifty up only 6 points, the Indian equity market is likely to open soft to negative.
Feb 01, 2016 at 07:48 | Source: Moneycontrol.com
Indian stocks are likely to open firmly in the green, tracking strength in Asian markets, after a surprise monetary intervention by the Bank of Japan boosted sentiment for risk assets.
Jan 29, 2016 at 07:56 | Source: Moneycontrol.com
In the US equities, stocks closed higher as a rise in oil and gains in Facebook outweighed pressure from declines in biotech stocks and concerns about economic growth